Research Results
Beta Version
Use the search bar below to find studies, or apply one or more filters to narrow your results. See our list of keywords to guide your search.
Search by keyword
Select
Select
- All Risk Factors
- Air Pollution
- Alcohol
- Antimicrobials
- Artificial sweeteners
- Bisphenols
- Body Weight
- Breast Density
- Chemical Mixtures
- Chemicals in products
- Cleaning Products
- Diet
- Exercise
- Family History
- Furniture & Electronics
- Genetics
- Gut Health
- Hair Dye
- Hormones
- Inflammation
- Job
- Light at night
- Metals
- Neighborhood
- Night Shift Work
- Noise
- Non-stick Pans & Waterproof Gear
- Oral Contraceptives
- PAHs
- Parabens
- PCBs
- Personal Care Products
- Pesticides
- PFAS
- Pharmaceuticals
- Place-based
- Plastic
- Pregnancy & Breastfeeding
- Processed Food
- Puberty Age
- Race/Ethnicity
- Radiation
- Red meat
- Scented Products & Soft Plastic
- Sleeping Patterns
- Soda
- Stress
- Sugar
- Sunscreen
- Tobacco
- Vitamin D
Select
Select
Select
Select
Select the Chemical Agents
- All Chemical Agents
- 1,1,2,2-TCA
- 1,3-Butadiene
- Acrolein
- Aldrin
- Alkylphenols
- Antimicrobials
- Antimicrobials: QACs, Triclosan, Triclocarban
- Aromatic Amines
- Arsenic
- Artificial Sweeteners
- Atrazine
- Benzene
- Bisphenols
- Cadmium
- Chlordane
- Chlorpyrifos
- DDT
- Dibutyl Phthalate
- Dichlorvos
- Dieldrin
- Dioxins
- ell/
- Ethanol (alcohol)
- Ethyl Benzene
- Ethylene Oxide
- Flame Retardants
- Food
- Formaldehyde
- Glyphosate
- Heptachlor
- Hormones
- Insulin
- Lead
- Light at Night
- Mercury
- Metals
- Methoxyclor
- Naphthalene
- Night Shift Work
- Nitrogen Dioxide
- Noise
- Oral Contraceptives
- Organochlorine Pesticides
- Organophosphate Pesticides
- Ozone
- PAHs
- Parabens
- Particulate Matter
- PCBs
- Pesticides
- PFAS
- Phenols
- Phthalates
- Processed Food
- PVC
- Radiation: Ionizing
- Radiation: Non-Ionizing
- Soda
- Stress
- Sugar
- Tobacco
- Toluene
- Trichloroethylene
- Triclosan
- Ultraviolet Radiation
- UV Filters
- Vinyl Chloride
Select the Study Tags
Sort By
- Relevance
- Title (A to Z)
- Title (Z to A)
- Publication Year (Ascending)
- Publication Year (Descending)
- Authors (A to Z)
- Authors (Z to A)
2025
J Hazard Mater
This study investigated whether DEHCH, a newly developed alternative plasticizer, has safer endocrine-disrupting effects compared to conventional phthalates and other alternative plasticizers using computer modeling, cell studies, and zebrafish testing. The researchers found that DEHCH showed lower binding affinity to hormone receptors and did not affect hormone-related gene expression or neurosteroid levels in zebrafish, unlike the other tested plasticizers. In contrast, conventional phthalates (DEHP, DINP) and previously proposed alternatives (DINCH, DEHTP) caused hyperactivity in zebrafish and altered hormone-related gene expression and neurosteroid concentrations. The results suggest that DEHCH may be a safer alternative to both conventional phthalates and previously proposed substitutes in terms of endocrine disruption and neurological effects.
2025
Int J Hyg Environ Health
New research highlights the link between endocrine-disrupting chemicals (EDCs) and earlier breast development in girls. A systematic review of 68 studies found that 10 out of 14 high-quality studies linked prenatal and postnatal exposure to EDCs like organohalogenated compounds and phthalates to earlier thelarche. With thelarche now occurring nearly three months earlier per decade, these findings raise serious concerns about long-term health risks, including breast cancer. Reducing exposure to harmful chemicals in everyday products is crucial to protecting hormonal health and preventing early puberty.
2025
Sci Rep
A large U.S. study of 4,455 people found that exposure to triclosan (TRS)—an antibacterial chemical commonly found in soaps, toothpaste, and personal care products—was associated with more than double the risk of breast cancer at moderate exposure levels, with the relationship following an inverted U-shape pattern. The association was strongest among overweight individuals, people under 60 years old, and white participants, while other tested chemicals (including bisphenol A, benzophenone-3, and parabens) showed no significant link to breast cancer risk. These findings suggest that triclosan exposure may be an important modifiable risk factor for breast cancer, particularly for certain population groups, though more research is needed to understand the underlying mechanisms and confirm causality.
2025
Sci Totl Environ
This study investigated the effects of three common plastic additives (DEHP, BPA, and benzotriazoles) on Atlantic cod liver tissue using precision-cut liver slices exposed to various concentrations of these chemicals individually and in mixtures. The researchers found that BPA and chemical mixtures caused estrogenic effects, significantly increasing vitellogenin (a female egg protein) production and related gene expression in male juvenile cod. The study also observed changes in liver metabolism genes, with mixture exposures showing potentially different effects than individual chemical exposures. The results suggest these plastic additives can disrupt hormone systems in fish, with BPA being the primary driver of estrogenic effects, though the interaction effects between chemicals require further investigation.
2024
Environ Res
Endocrine Disrupting Chemicals (EDCs)—including bisphenol A, phthalates, parabens, pesticides, and heavy metals commonly found in pharmaceuticals, cosmetics, and packaging—are widespread environmental pollutants that interfere with the body’s hormone system. Research shows EDCs have harmful effects on women’s reproductive health, contributing to conditions such as endometriosis, polycystic ovary syndrome, uterine fibroids, premature ovarian failure, menstrual irregularities, and infertility. This review emphasizes the need for healthcare professionals to consider environmental exposures when evaluating patients, highlights potential mechanisms by which EDCs affect female reproduction, and discusses how nutritional interventions and stricter environmental regulations could help reduce EDC-related health risks. Understanding the link between EDCs and women’s health is crucial for developing protective strategies, informing treatment approaches, and shaping public policies to safeguard reproductive and overall well-being. The study seeks to advise that couples attempting to conceive should avoid endocrine disrupting chemicals (EDCs) such as BPA, pesticides, and phthalates. Following this advice is found to be crucial during the prenatal and periconceptional periods, where fetal development and growth are critical in this window.
2024
Environ Toxicol Pharmacol
A comprehensive review examines endocrine-disrupting chemicals (EDCs) classified as carcinogens—compounds recognized for decades as top priority toxicants and persistent organic pollutants due to their ability to disrupt endocrine signaling—analyzing their hazard identification, human exposure routes, carcinogenic potency, and mechanisms of action across different organs. The review discusses major endocrine-disrupting carcinogens and their cancer-causing potential while identifying critical research gaps, methodological bottlenecks, and limitations in analytical detection techniques. This analysis underscores the serious public health concern posed by EDCs with carcinogenic properties, highlighting the need for improved understanding of their mechanisms, better analytical methods for detection and measurement, and addressing research limitations to protect human health from these ubiquitous environmental contaminants that can both disrupt hormonal systems and initiate cancer development.
2024
BMC Pub Health
This study used NHANES 2011–2018 data (n = 6,147) to evaluate the association between DEHP exposure and cancer risk. After adjusting for confounders, DEHP and its metabolites were significantly associated with increased risk of overall cancer prevalence, especially female reproductive system cancers (OR > 1.0, p < 0.05).
2024
Environ Int
A study in mice found that exposure to DEHP—a common chemical used to make plastics flexible—disrupts the gut-mammary connection, causing changes in gut bacteria, intestinal inflammation, and direct damage to mammary (breast) tissue that could impair milk production. DEHP altered gut microbiome composition (increasing some bacteria while decreasing others), changed blood metabolite levels, and its breakdown product (MEHP) triggered cell death in mammary tissue through multiple pathways. These findings raise concerns about DEHP exposure from plastics affecting both human breast health and dairy production in livestock, while identifying potential therapeutic targets to counteract the chemical’s harmful effects on the gut-breast axis.
2024
Int J Env Res Pub Health
This study surveyed 746 Kenyan women about their hair product use and found that nearly 60% had used chemical relaxers and one-third had used hair dyes, despite many expressing concerns about health risks including breast cancer. Older women and those working in sales and service industries were more likely to use these products, which may contain endocrine-disrupting chemicals linked to breast cancer. Surprisingly, women’s awareness of potential health risks did not consistently lead to reduced use of these products, suggesting that concern alone may not be enough to change behavior. These findings are particularly important for Kenya, where breast cancer rates are rising, and highlight the need for better education about chemical exposures in hair products and strategies to reduce potentially harmful exposures.
2024
Crit Rev Toxicol
A meta-analysis of 13 observational studies through May 2022 examined the dose-response relationship between per- and polyfluoroalkyl substances (PFAS) exposure—including PFOS, PFOA, PFNA, PFDA, and PFHxS—and risk of breast, prostate, colorectal, and ovarian cancers. The highest versus lowest exposure analysis found no significant associations between any PFAS compound and breast cancer (ORs ranging from 0.88-1.29), ovarian cancer (OR = 1.43), prostate cancer (OR = 1.05), or colorectal cancer (OR = 0.77). However, linear dose-response analysis revealed unexpected inverse associations, with each 1 ng/ml increase in PFNA and 2 ng/ml increase in PFOA associated with significant decreases in breast cancer risk (RR = 0.67 and 0.94, respectively), though non-linear analysis found no significant changes. The findings provide no evidence that PFAS exposure increases cancer risk for these sites, and the unexpected inverse associations observed in linear dose-response analyses—suggesting potential protective effects—are unexplained and may reflect study artifacts, reverse causation, or confounding factors rather than true biological protection, warranting further investigation to clarify these paradoxical relationships and determine whether they reflect real phenomena or methodological limitations.
2024
PNAS
This study examined the health impacts of three major plastic-associated chemicals—BPA, DEHP, and PBDEs—across 38 countries representing one-third of the global population. The researchers found that in 2015, these chemicals were linked to approximately 5.4 million cases of heart disease, 346,000 strokes, 164,000 deaths among older adults, and 11.7 million lost IQ points in children due to prenatal exposure. The total economic cost of these health impacts was estimated at $1.5 trillion. The study suggests that if exposure levels had been reduced earlier, hundreds of thousands of deaths and millions of IQ points could have been prevented.
2024
Breast Cancer Res Treat
A meta-analysis of 10 randomized controlled trials including 14,282 participants and 591 breast cancers found that estrogen-alone hormone therapy was associated with a significant 23% reduction in breast cancer incidence (3.6% vs 4.7% in estrogen vs placebo groups, RR 0.77, 95% CI 0.65-0.91, P=0.002). This finding was driven primarily by the large Women’s Health Initiative trial but was supported by nine smaller trials showing similar directional effects, with estradiol formulations showing a 37% non-significant risk reduction. These results from randomized trials contradict findings from observational cohort studies and challenge conventional wisdom about hormone therapy and breast cancer, suggesting that estrogen-alone therapy (in women without a uterus) may actually protect against breast cancer rather than increase risk—a finding with important implications for counseling postmenopausal women about menopausal hormone therapy decisions.
2024
Heliyon
A mouse study found that ginger volatile oil (GVO) reduced triple-negative breast cancer tumor growth in animals exposed to bisphenol A (BPA), a common plastic chemical known to promote cancer, with the effect linked to restoration of healthy gut bacteria. BPA exposure disrupted the gut microbiome by reducing bacterial diversity and beneficial bacteria like Lactobacillus, but treatment with ginger oil reversed these changes and increased the ratio of beneficial bacteria while decreasing harmful bacteria. The findings suggest that ginger compounds may counteract BPA’s cancer-promoting effects through their impact on the gut microbiome, offering a potential dietary strategy to mitigate harm from plastic chemical exposure, though human studies are needed to confirm these results.
2023
Frontiers
This meta-analysis aimed to evaluate the association between exposure to endocrine-disrupting chemicals (EDCs), including phthalates and other common environmental pollutants, and breast cancer risk. The study found that certain EDCs—such as p,p′-DDT, chlordane, HCH, and specific PCBs—were positively associated with increased breast cancer risk, while a few compounds like BBP and PFDoDA showed a negative association.
2023
Toxicol Sci
A high-throughput transcriptomic study using MCF-7 breast cancer cells exposed to BPA and 15 alternative chemicals (0.0005-100 µM for 48 hours) found that 8 alternative chemicals activated estrogen receptor alpha (ERα), with bisphenol AF identified as the most potent, followed by BPA and bisphenol C, and benchmark concentration analysis revealing that BPA and transcriptionally active alternatives enriched similar gene sets associated with increased cell division and cancer-related processes at comparable concentrations. Global transcriptomic and ERα-specific points of departure produced highly consistent potency rankings, and pathway analysis showed that active alternatives induced hazards similar to BPA through shared molecular mechanisms. These findings reveal that many BPA replacement chemicals used since initial 2010 Canadian regulatory action are not safer alternatives and may pose similar or greater hazards at comparable exposure levels despite being data-poor compounds with limited toxicological assessment, supporting the use of transcriptomic profiling for read-across risk assessment of structurally related chemicals and raising concerns about regrettable substitution in which one harmful chemical is simply replaced with equally harmful alternatives.
2023
Eur J Nutr
A large prospective cohort study of 67,879 French women followed for 21 years found that higher dietary inflammatory potential was associated with a 4% increased breast cancer risk per standard deviation increase in DII score, with women in the highest versus lowest quintile showing a 13% increased risk in a linear dose-response relationship. The association was slightly stronger among non-smokers (6% increased risk per standard deviation) and low alcohol consumers (5% increased risk per standard deviation), suggesting that inflammatory diet effects may be most pronounced in women without other pro-inflammatory exposures. These findings from one of the largest and longest prospective studies provide strong evidence that promoting anti-inflammatory dietary patterns—rich in fruits, vegetables, whole grains, legumes, nuts, and fish while limiting processed foods, red meat, refined carbohydrates, and saturated fats—could contribute meaningfully to breast cancer prevention as part of comprehensive public health strategies.
2023
Endocrinology
Methylparaben (MP) and propylparaben (PP) are preservatives commonly found in food, and cosmetics which activate estrogen receptors (ER) in the body. Research shows that these parabens can promote mammary tumor growth and metastasis. This study tested female mice with exposure to MP and PP within levels deemed safe by the FDA. Even within FDA approved levels, there was significant increase in mammary tumor volume. Cellular analysis revealed that these parabens affected the expression of genes, some linked to breast cancer. This research highlights potential risks of parabens in promoting breast cancer.
2023
Environ Health Perspect
A case-cohort study within the prospective Cancer Prevention Study II (CPS-II) LifeLink cohort examined associations between serum per- and polyfluoroalkyl substances (PFAS) concentrations and cancer risk by analyzing blood samples collected 1998-2001 from 999 randomly selected participants and 3,762 cancer cases (breast, bladder, kidney, pancreas, prostate, and hematologic cancers), with particular attention to histologic subtypes. The study found that higher serum PFOA concentrations were positively associated with renal cell carcinoma in women (HR per PFOA doubling: 1.54; 95% CI: 1.05-2.26) but not men, while higher PFHxS concentrations were associated with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in men (HR per PFHxS doubling: 1.34; 95% CI: 1.02-1.75), with some variation in associations observed across histologic subtypes within cancer sites. These findings in a general population cohort support previous observations linking PFOA to kidney cancer in women and identify a new association between PFHxS and CLL/SLL in men, highlighting the importance of considering both sex differences and specific histologic cancer subtypes when evaluating PFAS-cancer relationships. The study demonstrates that PFAS exposure at levels found in the general U.S. population may be associated with increased risk of certain cancers, extending concerns beyond highly exposed occupational or community populations.
2023
Environ Sci Technol
The following study discusses a strategic framework to improve how chemicals are managed in North America. The Essential-Use Approach is a policy that prioritizes restricting the use of chemicals based on necessity and safety. It proposes three guiding questions: Is the chemical essential to the product’s function? Is it the safest option? Is it necessary for health and safety? They also prioritize speed of assesments so that chemicals can be quickly phased out if evidence suggests danger to human health. This study is a call for change and aims to become a tool to simplify decision-making for regulating organizations, help businesses avoid liability related to harmful chemicals, and ultimately improve public health by ensuring only the safest substances are used in consumer products.
2022
Biomed Pharmacother
A review of endocrine-disrupting chemicals (EDCs)—ubiquitous substances found in cosmetics, plastic food packaging, and medicines that enter the body through skin, digestive, or respiratory routes—examined their toxic effects even at microgram doses on the female reproductive system and genetic mechanisms. EDCs disrupt endocrine functions by binding to steroid hormone receptors, interfering with hormone synthesis and secretion, and modulating epigenetic processes that can lead to gene expression disturbances, contributing to neoplastic diseases, neurological disorders, circulatory problems, and reproductive dysfunction. Prenatal exposure can affect offspring development, with particular impacts on ovarian function leading to reduced fertility through disturbances in steroid receptor function, steroidogenesis, and gametogenesis. The review emphasizes that despite widespread exposure to these chemicals in everyday products, continued research is needed to fully understand their effects on the female reproductive system and potential transgenerational impacts mediated through epigenetic mechanisms.
2022
Ecotoxicology
An experimental study using wild-type and thyroid hormone receptor alpha knockout (thrαa⁻/⁻) zebrafish embryos/larvae found that avobenzone and octinoxate—organic UV filters commonly used in sunscreens and widely detected in water—disrupt the thyroid endocrine system, with significantly lower survival rates in thrαa⁻/⁻ fish exposed to ≥3 μM of either compound, indicating the thyroid hormone receptor plays a crucial role in their toxicity. Avobenzone exposure increased the T3:T4 ratio with upregulation of the deio2 gene, while both chemicals decreased T4 levels and triggered compensatory upregulation of hypothalamus and pituitary genes (trh, tshβ, tshr), indicating feedback mechanisms attempting to maintain hormonal homeostasis. These findings demonstrate that two widely used sunscreen ingredients act as thyroid endocrine disruptors by affecting thyroid hormone receptors and disrupting the hypothalamus-pituitary-thyroid (HPT) axis, raising concerns about aquatic environmental contamination from these chemicals and potential impacts on thyroid function in exposed organisms, including implications for human exposure through water and dermal application.
2022
Crit Rev Food Sci Nutr
This systematic review of 131 epidemiological studies evaluated the association between various endocrine-disrupting chemicals, including phthalates and hormonal exposures like contraceptive pills, and the risk of breast cancer. It found that several EDCs, particularly phthalates and oral contraceptive use, were consistently associated with increased breast cancer risk across multiple studies.
2022
Endocrinology
A review examining PFAS (found in nonstick cookware, food packaging, and stain-resistant fabrics) and parabens (used in personal care products) found that exposure to these endocrine-disrupting chemicals is linked to breast cancer development, with marginalized and socially disadvantaged communities facing disproportionately higher exposures due to structural racism and inequitable environmental conditions. These disparities in chemical exposure may contribute to poorer breast cancer outcomes in these populations, yet breast cancer research continues to underrepresent these communities, limiting our ability to address treatment disparities and improve survival rates. The authors emphasize the urgent need to both reduce EDC exposures in vulnerable communities and increase research inclusion of diverse populations to understand how environmental injustices intersect with breast cancer risk and develop interventions that address these health inequities.
2022
Int J Environ Res Public Health
A recent study highlights the risk of Bisphenol A (BPA) exposure from bottled water, emphasizing how temperature can influence BPA leaching into the water. While BPA isn’t used in PET bottle manufacturing, contamination can occur due to recycled materials. Findings indicate that BPA levels in bottled water increase with temperature, even when not at the highest temperatures. BPA, a known endocrine-disrupting chemical (EDC), is linked to reproductive health issues, developmental disorders, and even cancer.
2022
Biomedicines
This study investigates the effects of di-(2-ethylhexyl) phthalate (DEHP), a common plasticizer, on female rats. It found that exposure to DEHP, even at realistic environmental doses, led to significant disruptions in the rats’ reproductive and thyroid systems. More specifically it found that even low exposure to DEHP over a period of 21 days resulted in a significant decrease in the levels of estrogen and progesterone, which correlated with damage to ovarian follicles. Additionally, the thyroid showed signs of damage, including alterations in hormone regulation. The data in this study suggests that DEHP can potentially lead reproductive issues and impaired ovarian and thyroid gland function.
2022
Clin Breast Cancer
A case-control study of 150 Iranian women with newly diagnosed breast cancer matched with 150 controls found that women consuming the most pro-inflammatory diets (highest quartile of food-based dietary inflammatory index) had a 138% increased breast cancer risk compared to those with the least inflammatory diets, with the association remaining significant (180% increased risk) after adjusting for confounding factors. The food-based empirical dietary inflammatory index (FDII), which scores dietary patterns based on 27 pre-defined food groups according to their inflammatory potential, showed a clear dose-response relationship with breast cancer risk across quartiles. These findings from a Middle Eastern population reinforce that dietary patterns promoting systemic inflammation substantially increase breast cancer risk, and suggest that practical, food-based dietary modifications—emphasizing anti-inflammatory whole foods like fruits, vegetables, whole grains, legumes, nuts, and fish while limiting pro-inflammatory processed foods, red meat, and refined carbohydrates—could be an effective and culturally adaptable breast cancer prevention strategy.
2022
Molec Carcinogen
A case-control study of 708 breast cancer patients and 598 controls from Long Island found that paraben exposure—particularly methylparaben—was associated with significantly increased breast cancer risk among women with hypomethylated (undermethylated) DNA, showing a 46% increased risk in the highest versus lowest exposure group and a 32% increased risk per one-quantile increase in combined paraben exposure. Importantly, paraben exposure was specifically associated with breast tumors characterized by hypomethylation of the CCND2 gene promoter, with methylparaben showing a 25% increased risk and combined parabens showing a 55% increased risk for this tumor subtype. These findings suggest that parabens—ubiquitous preservatives in personal care products—may contribute to breast cancer development through epigenetic mechanisms, particularly in women with pre-existing DNA methylation abnormalities, identifying a potentially vulnerable subpopulation and a specific molecular pathway through which these chemicals may promote carcinogenesis.
2021
Environ Res
Biodegradable polymers are emerging as a promising solution for removing endocrine-disrupting chemicals (EDCs) from wastewater. EDC’s, found in pharmaceuticals, pesticides, and personal care products pose serious health risks, impacting the endocrine system and disrupting reproductive health. Traditional water treatments often fail to fully remove EDCs. Biodegradable polymers, with strong adsorptive properties, offer a sustainable and effective method, helping to minimize EDC exposure and protect human and environmental health.
2021
Adv Pharmacol
A comprehensive review examining endocrine-disrupting chemicals (EDCs) in breast tissue concludes that hundreds of these environmental chemicals are entering human breast tissue and contributing to the global rise in breast cancer incidence through multiple biological mechanisms. Laboratory studies demonstrate that EDCs can activate all the established “hallmarks of cancer” in human breast cancer cells—even at concentrations measured in actual human breast tissue—with effects amplified when chemicals are present as mixtures rather than individually. The authors argue that EDCs must now be formally recognized as a breast cancer risk factor to enable prevention strategies that include reducing environmental chemical exposures, particularly given that the varied mixtures of EDCs found in individual breast tissues act through overlapping mechanisms to promote cancer development.
2021
Eur J Epidemiol
A large prospective study of 318,686 European women followed for 14 years found that consuming a pro-inflammatory diet was associated with a 4% increased breast cancer risk per standard deviation increase in inflammatory diet score, with women in the most pro-inflammatory diet group showing a 12% increased risk compared to those consuming the least inflammatory diets. The association was particularly strong in premenopausal women (8% increased risk per standard deviation), and notably, the pro-inflammatory diet effect was independent of body mass index, physical activity, and alcohol consumption, suggesting that dietary inflammation contributes to breast cancer risk through pathways distinct from these other established risk factors. The consistent associations across all hormone receptor-defined breast cancer subtypes suggest that dietary inflammation may promote breast cancer through non-hormonal mechanisms, reinforcing the importance of anti-inflammatory dietary patterns—rich in fruits, vegetables, whole grains, and omega-3 fatty acids while limiting processed foods, red meat, and refined carbohydrates—as a modifiable strategy for breast cancer prevention across all women, particularly those still premenopausal.
2021
Nutr Cancer
A case-control study of 317 breast cancer patients and 526 controls in Córdoba, Argentina found that women consuming the most pro-inflammatory diets (highest Dietary Inflammatory Index scores) had a 34% increased breast cancer risk compared to those with the least inflammatory diets. The association was markedly stronger among overweight and obese women, who showed a 98% increased risk with pro-inflammatory diets, and the effect was amplified in more urbanized areas compared to rural settings. These findings suggest that dietary patterns promoting systemic inflammation contribute to breast cancer risk, particularly in combination with obesity and urban lifestyle factors, highlighting the potential for dietary interventions focused on anti-inflammatory foods as a prevention strategy, especially in overweight women living in urban environments.
2020
Mol Cell Endocrinol
A review of EPA pesticide registration documents found that 28 pesticides cause mammary tumors in animals and five alter mammary gland development, yet the agency’s risk assessments often dismiss these findings or don’t evaluate their implications for breast cancer risk. Many of these pesticides work through hormone-disrupting pathways that could affect breast tissue, including common chemicals like malathion, atrazine, and triclopyr. The authors argue that current testing guidelines don’t adequately assess effects on the mammary gland and call for re-evaluation of several widely-used pesticides based on stronger standards informed by breast cancer biology.
2020
Environ Res
A systematic review of 100 publications across 56 epidemiologic studies found that research enriched with women at higher baseline breast cancer risk—through family history, early-onset disease, or genetic susceptibility—consistently showed stronger and more frequent associations between environmental chemical exposures and breast cancer compared to average-risk populations. Specifically, 80% of studies enriched with family history or early-onset cases showed significant associations with exposures including PAHs, air pollution, DDT, PCBs, PFAS, metals, personal care products, and occupational chemicals, while 74% of studies examining genetic susceptibility found significant gene-environment interactions for various pollutants in women with variants affecting carcinogen metabolism, DNA repair, and oxidative stress. These findings suggest that the inconsistent evidence for environmental chemicals and breast cancer in the literature may partly stem from studying predominantly average-risk populations who may be less susceptible to environmental carcinogens, highlighting the critical need for future research to focus on high-risk populations and measure exposures during key windows of susceptibility (puberty, pregnancy, menopause) to more accurately capture the role of environmental chemicals in breast cancer development.
2019
PLOS One
Bisphenol AF (BPAF)—a chemical increasingly used to replace BPA in consumer products—shows even stronger estrogen-like effects than BPA and promotes the growth of estrogen receptor-positive (ER+) breast cancer cells through multiple hormone signaling pathways. Laboratory studies revealed that BPAF stimulates cancer cell proliferation by activating estrogen receptors and upregulating AREG, a growth-promoting gene, with blocking either estrogen receptors or AREG preventing BPAF’s cancer-promoting effects. These findings challenge the assumption that BPA alternatives are safer, demonstrating that BPAF may pose equal or greater breast cancer risks than the chemical it’s replacing, and highlight the urgent need for human studies to assess BPAF’s impact on breast cancer risk before its continued widespread use in products marketed as “BPA-free.”
2019
J Expo Sci Environ Epidemiol
This study from a longitudinal cohort of 133 women diagnosed with breast cancer before age 50 and 133 age-matched controls without breast cancer. DDT is stored in adipose tissue, and the authors found that serum DDE (the main metabolite of DDT) was inversely associated with BMI amont women who were cancer-free, but that this association did not hold among women diagnosed with breast cancer before age 50. The authors suggest that early exposure to breast cancer among women exposed to DDT may be due to an uncoupling of the relationship between BMI and serum DDT, and that this may reveal biomarkers of risk through further research.
2019
Eur J Clinic Nutr
A meta-analysis of seven observational studies including 319,993 participants found that women consuming the most pro-inflammatory diets (highest DII scores) had a 25% increased breast cancer risk compared to those with the least inflammatory diets, with particularly strong associations observed in postmenopausal women (15% increased risk) and hormone receptor-negative breast cancers (36% increased risk). The association varied by geography, showing dramatically elevated risk in Asian populations (130% increase) and more modest effects in European populations (26% increase), while case-control studies showed stronger associations (68% increase) than cohort studies. These findings reinforce that dietary patterns promoting chronic systemic inflammation—typically characterized by high intake of refined carbohydrates, red/processed meats, and trans fats with low intake of fruits, vegetables, and omega-3 fatty acids—contribute meaningfully to breast cancer risk, supporting dietary interventions focused on anti-inflammatory foods as a practical prevention strategy.
2018
Mol Cell Endocrinol
A review examining parabens—one of the most widely used preservatives worldwide in foods, cosmetics, and pharmaceuticals—found that these easily absorbed chemicals are classified as endocrine-disrupting chemicals (EDCs) that can disrupt hormonal homeostasis and cause multidirectional health implications affecting body fitness and function. The review summarizes current literature on paraben properties, occurrence, metabolism, and particularly their influence on the human endocrine system, emphasizing the importance of assessing their safety given their ubiquitous use and absorption. With parabens now recognized as EDCs capable of disrupting endocrine function, the authors highlight concerns about widespread population exposure through everyday consumer products and the need for precise assessment of their health impacts on human physiology.
2018
Environ Health
A nested case-control study within the California Teachers Study examined 902 women with invasive breast cancer and 858 controls who provided blood samples an average of 35 months after case diagnosis to assess whether serum concentrations of six per- and poly-fluoroalkyl substances (PFASs)—PFOA, PFNA, PFUnDA, PFHxS, PFOS, and MeFOSAA—were associated with breast cancer risk. For all invasive breast cancers combined, none of the adjusted odds ratios were statistically significant, though marginally significant inverse associations were observed for PFUnDA and PFHxS; statistically significant inverse associations for these two compounds were found only among the 107 women with hormone receptor-negative tumors, not among the 743 with hormone-positive tumors. The authors conclude that the study provides no evidence that post-diagnosis serum PFAS levels are related to breast cancer risk, and suggest that the few inverse associations observed may be due to chance or study design artifacts, particularly because measurements were taken after diagnosis rather than before. Future research should include pre-diagnosis PFAS measurements, genetic susceptibility factors, and endogenous estrogen levels to better assess whether these widely used synthetic chemicals—some of which are known mammary toxicants and endocrine disruptors—influence breast cancer development.
2018
Food Chem Tox
A systematic review of 25 studies examining phthalates (plastic chemicals) and breast cancer found that while laboratory studies show certain phthalates can activate estrogen receptors and promote cancer cell growth, epidemiological studies in humans have produced mixed and inconclusive results. The main source of phthalate exposure is through diet—particularly from food and beverages in plastic packaging—but current human studies have significant limitations in how they measure exposure and account for other risk factors. The review calls for better-designed future studies that use hair samples instead of urine for more accurate long-term exposure assessment, include dietary factors and genetic markers as confounders, and investigate phthalates’ effects beyond just estrogen-driven cancers to include all breast cancer subtypes.
2018
Nutr Cancer
A case-control study of 136 breast cancer patients and 272 controls in Iran found that women consuming the most pro-inflammatory diets (highest quartile of DII scores) had a 164% increased breast cancer risk compared to those with the least inflammatory diets, with the association particularly striking among premenopausal women who showed a 451% increased risk. No association was detected in postmenopausal women, contrasting with findings from other studies that have typically shown stronger effects in postmenopausal populations. These findings suggest that pro-inflammatory dietary patterns may be especially harmful during premenopausal years when breast tissue is more metabolically active and hormone-responsive, highlighting the potential importance of anti-inflammatory dietary interventions—emphasizing whole grains, fruits, vegetables, legumes, nuts, and fish while limiting processed foods, red meat, and refined carbohydrates—as a targeted prevention strategy for younger women at risk of breast cancer.